ID   KMBC
AC   CVCL_M267
DR   BTO; BTO_0003309
DR   Cosmic; 924010
DR   Wikidata; Q54900100
RX   CelloPub=CLPUB00275;
RX   PubMed=1312890;
RX   PubMed=7537711;
RX   PubMed=9824643;
RX   PubMed=21533411;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=1312890); 67 hours (PubMed=9824643).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
RX   CelloPub=CLPUB00275;
RA   Zach S., Birgin E., Ruckert F.;
RT   "Primary cholangiocellular carcinoma cell lines.";
RL   J. Stem Cell Res. Transplant. 2:1013-1013(2015).
//
RX   PubMed=1312890; DOI=10.1002/1097-0142(19920401)69:7<1664::AID-CNCR2820690705>3.0.CO;2-P;
RA   Yano H., Maruiwa M., Iemura A., Mizoguchi A., Kojiro M.;
RT   "Establishment and characterization of a new human extrahepatic bile
RT   duct carcinoma cell line (KMBC).";
RL   Cancer 69:1664-1673(1992).
//
RX   PubMed=7537711; DOI=10.1002/hep.1840210510;
RA   Haramaki M., Yano H., Fukuda K., Momosaki S., Ogasawara S., Kojiro M.;
RT   "Expression of CD44 in human hepatocellular carcinoma cell lines.";
RL   Hepatology 21:1276-1284(1995).
//
RX   PubMed=9824643; DOI=10.3892/ijo.13.6.1269;
RA   Koike N., Todoroki T., Kawamoto T., Yoshida S., Kashiwagi H.,
RA   Fukao K., Ohno T., Watanabe T.;
RT   "The invasion potentials of human biliary tract carcinoma cell lines:
RT   correlation between invasiveness and morphologic characteristics.";
RL   Int. J. Oncol. 13:1269-1274(1998).
//
RX   PubMed=21533411; DOI=10.3892/ijo.10.3.545;
RA   Moon Y., Dahlberg W.K., Yu Y.-J., Ohno T., Todoroki T., Little J.B.;
RT   "Radiosensitivity of human biliary tract cancer cell lines in vitro.";
RL   Int. J. Oncol. 10:545-551(1997).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//